Wall Street expects a year-over-year increase in earnings on higher revenues when ResMed (RMD) reports results for the ...
Zacks Investment Research on MSN
AstraZeneca gets accelerated FDA nod for Ultomiris in IgA nephropathy
AstraZeneca AZN announced that the FDA has approved its blockbuster rare disease drug, Ultomiris (ravulizumab), for reducing ...
With a late Thursday nod from the FDA to reduce protein levels in the urine of patients with primary immunoglobulin A ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
FDA granted accelerated approval for Ultomiris to treat primary IgA nephropathy.AstraZeneca reports annual revenue of $58.74B ...
阿斯特捷利康 (AZN) 盤中上漲3.04%，所屬行業 醫藥與醫學研究 上漲1.42%，公司漲幅跑贏行業漲幅，行業成交額前三股票 Moderna Inc (MRNA) 下跌 24.58%； Eli Lilly and Co (LLY) 上漲 3.16 ...
Rødspættefileter, fiskefrikadeller og torskeloins er genkendelige størrelser for de fleste danskere. Man kender dem fra ...
Orforglipron是一种口服非肽类GLP-1受体激动剂，目前非肽类GLP-1受体激动剂的心血管安全性尚缺乏研究。《柳叶刀》（The ...
En rebond à l’allocution d’Emmanuel Macron, dans laquelle il a affirmé que « rien n’expliquait » les violences du 17 octobre, ...
Pour remplir son objectif de contrôler 1,5 million de personnes, France Travail mise sur l’intelligence artificielle. Des ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results